A Pancreatitis‐Inspired Trypsinogen Nanoplatform Reprograms Tumor‐Associated Macrophages via NF‐κB for Pancreatic Cancer Immunotherapy
Advanced Science · 2026
DOI: 10.1002/advs.76386 ↗At a glance
Journal article in Advanced Science, 2026. Written by Lei Cao and 7 co-authors. Institution: Department of Radiology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology o…. Major MEDLINE topics: Pancreatic Neoplasms, Immunotherapy, Tumor-Associated Macrophages, NF-kappa B. 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Sichuan Science and Technology Program, Shanghai Targeted Biomedicine Project.
Abstract (original language)
Although reprogramming tumor‐associated macrophages (TAMs) represents a promising therapeutic strategy, approaches that are both precise and safe remain scarce. Inspired by the pro‐inflammatory M1‐like response triggered by trypsinogen in pancreatitis, trypsinogen as a novel macrophage reprogrammer is identified. Here, it is shown that trypsinogen drives M2‐to‐M1 repolarization via NF‐κB activation. To harness this activity, a pancreatitis‐inspired nanoplatform (JT@NPs‐aCD11b) co‐delivering trypsinogen and the CD47 inhibitor JQ1 to TAMs is developed. In pancreatic cancer models, JT@NPs‐aCD11b reprogrammed TAMs to an M1 phenotype while JQ1 blocked the “do not eat me” signal on cancer cells, synergistically enhancing phagocytosis. This strategy remodeled the immunosuppressive microenvironment, increased effector immune cells, and reduced suppressive populations, leading to potent tumor suppression, prolonged survival, and durable immune memory. Macrophage depletion abrogated efficacy, confirming TAMs as the primary mediators. This work establishes trypsinogen as a versatile immunomodulator and its nanoplatform as a promising strategy for pancreatic cancer immunotherapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Radiology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China.
- Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China.
- Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, P. R. China.
- Nanomedicine Innovation Research and Transformation Institute, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, P. R. China.
Funding
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Shanghai Targeted Biomedicine Project
- Outstanding Youth Project of the Natural Science Foundation of Sichuan Province
- Innovative Team Project of Research and Development Plan of the Affiliated Hospital of North Sichuan Medical College
Cite
APA
Cao, L., He, Y., Li, W., Gong, B., Lin, H., Shi, J., Yong, Y., & Wu, W. (2026). A Pancreatitis‐Inspired Trypsinogen Nanoplatform Reprograms Tumor‐Associated Macrophages via NF‐κB for Pancreatic Cancer Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.76386
Vancouver
Cao L, He Y, Li W, Gong B, Lin H, Shi J, et al. A Pancreatitis‐Inspired Trypsinogen Nanoplatform Reprograms Tumor‐Associated Macrophages via NF‐κB for Pancreatic Cancer Immunotherapy. Advanced Science. 2026. doi:10.1002/advs.76386
BibTeX
@article{Cao2026,
author = {Cao, Lei and He, Yu and Li, Wenhao and Gong, Bo and Lin, Han and Shi, Jianlin and Yong, Yuan and Wu, Wencheng},
title = {A Pancreatitis‐Inspired Trypsinogen Nanoplatform Reprograms Tumor‐Associated Macrophages via NF‐κB for Pancreatic Cancer Immunotherapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76386}
}
EUVIMED